COMMUNIQUÉS West-GlobeNewswire

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

15/05/2024 - 18:00

MOUNTAIN VIEW, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the data from its REVEALPLAQUE study, [...]

PHAXIAM provides Business and Financial Update for the First Quarter of 2024

15/05/2024 - 17:45

PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15, 2024, at 6.00 pm CEST Accelerated clinical efforts to roll-out PHAXIAM’s strategy in order to create a [...]

PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024

15/05/2024 - 17:45

PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024 Webinaire (en français) ce jour à 18h00 : inscrivez-vous ici Accélération des développements cliniques en [...]

Ezra Partners with Princeton Radiology for Proactive, Whole-Body MRI Screenings to Support Earlier Cancer Detection

15/05/2024 - 17:00

NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Ezra , the healthcare AI startup transforming early cancer detection through full body MRI screening, today announced a new partnership with Princeton Radiology Associates, [...]

Mathew Hall, Sarcoidosis Warrior, Takes on Iron Man 70.3 Chattanooga to Raise Awareness and Support for Sarcoidosis

15/05/2024 - 16:24

CHICAGO, May 15, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) proudly announces Mathew Hall, a devoted supporter and sarcoidosis patient, will be competing in the upcoming Ironman 70.3 [...]

Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA

15/05/2024 - 16:00

Primary results of the Scemblix ® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the EHA Plenary Session [...]

Dew Aesthetics Unveils Cutting-Edge MedSpa Treatments in Baltimore, Pioneering a Path to Timeless Beauty

15/05/2024 - 16:00

BALTIMORE, Md., May 15, 2024 (GLOBE NEWSWIRE) -- Dew Aesthetics , the premier destination for cutting-edge medical spa treatments, is proud to announce the launch of its innovative services, revolutionizing the [...]

Dr. Bob Meyer D.C. Legacy in Sports Medicine Continues to Shine Bright: A Testament to Excellence

15/05/2024 - 16:00

AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- In the fast-paced world of sports medicine, few names command as much respect and admiration as Dr. Bob Meyer, D.C. With a career spanning decades, Dr. Bob has not only [...]

Alvotech S.A. Annual General Meeting to be held June 7, 2024

15/05/2024 - 15:30

The Annual General Meeting of Alvotech S.A. will be held on Friday June 7, 2024, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg, Grand Duchy of [...]

Vaso Corporation Announces Financial Results for First Quarter 2024

15/05/2024 - 15:00

PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. “Total revenue for the first quarter of 2024 was [...]

Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS

15/05/2024 - 15:00

Planegg/Martinsried, May 15, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]

Promex Broadens Leadership Team Expertise, Naming Matt Hansen Director of Sales and Business Development

15/05/2024 - 15:00

Hansen to leverage breadth of industry experience in targeting new markets SANTA CLARA, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Promex Industries , a Silicon Valley-based provider of advanced design, packaging and [...]

Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

15/05/2024 - 14:52

ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to [...]

CloudMD Announces Go-Private Transaction with CPS Capital

15/05/2024 - 14:46

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “ Company ” or “ CloudMD ”), an innovative health services company transforming the delivery of care, and [...]

Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement

15/05/2024 - 14:45

BOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to [...]

ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update

15/05/2024 - 14:35

Key Highlights: Second research site selected to enhance enrollment in the Phase 2a clinical trial for Cholesterol Efflux Mediator TM VAR 200 in patients with diabetic kidney disease planned to begin H1-2024. GLP [...]

Yield10 Bioscience Announces Delisting from Nasdaq

15/05/2024 - 14:30

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a final delisting notice [...]

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

15/05/2024 - 14:30

MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]

Sienna Announces May Dividend

15/05/2024 - 14:30

MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) for [...]